Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €704.78M | -3.3x | 0.62 | €11.22 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Valneva | Paris | Healthcare | Biotechnology & Medical Research | €454.19M | -18.6x | -0.23 | €3.28 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €225.65M | -4.4x | -0.16 | €4.78 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Genfit | Paris | Healthcare | Biotechnology & Medical Research | €207.10M | -7.2x | 0.33 | €4.06 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €194.01M | -3.9x | -0.22 | €0.65 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €167.71M | -22x | -0.26 | €2.12 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €166.72M | 38.3x | -0.43 | €16.60 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €164.24M | -6.4x | 0.27 | €7.61 | 10.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €144.91M | -2.1x | -0.05 | €2.03 | 13.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €117.29M | -0.9x | 0.01 | €2.25 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Transgene | Paris | Healthcare | Biotechnology & Medical Research | €107.16M | -4.8x | -0.15 | €1.06 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | €104.94M | -5.5x | 0.29 | €10.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Eurofins-Cerep | Paris | Healthcare | Biotechnology & Medical Research | €99.37M | 10.1x | €19,700 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | €95.81M | -3.3x | 0.04 | €6.42 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Abionyx Pharma SA | Paris | Healthcare | Biotechnology & Medical Research | €42.93M | -10.3x | -0.61 | €1.24 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Novacyt | Paris | Healthcare | Biotechnology & Medical Research | €41.57M | -1.2x | 0.12 | €0.59 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Genoway | Paris | Healthcare | Biotechnology & Medical Research | €35.59M | 22.7x | €3.95 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gensight Biologics | Paris | Healthcare | Biotechnology & Medical Research | €35.18M | -0.6x | -0.14 | €0.32 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Poxel SA | Paris | Healthcare | Biotechnology & Medical Research | €28.06M | -0.3x | €0.57 | 15% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NFL Biosciences | Paris | Healthcare | Biotechnology & Medical Research | €22.03M | €2.23 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Predilife | Paris | Healthcare | Biotechnology & Medical Research | €21.37M | -5x | 0.39 | €5.75 | -5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Oncodesign Precision Medicine | Paris | Healthcare | Biotechnology & Medical Research | €21.26M | -2.8x | €1.14 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valbiotis | Paris | Healthcare | Biotechnology & Medical Research | €21.24M | -2.3x | -0.05 | €1.35 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Phaxiam Therapeutics | Paris | Healthcare | Biotechnology & Medical Research | €19.32M | -0.4x | 0 | €1.92 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Plant Advanced Technologies SA | Paris | Healthcare | Biotechnology & Medical Research | €16.55M | 187.6x | €15.90 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acticor Biotech | Paris | Healthcare | Biotechnology & Medical Research | €8.47M | -0.4x | 0.2 | €0.48 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Quantum Genomics SA | Paris | Healthcare | Biotechnology & Medical Research | €6.63M | -1x | -0.03 | €0.10 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
TME Pharma NV | Paris | Healthcare | Biotechnology & Medical Research | €5.93M | -0.1x | -0.01 | €0.14 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Theranexus | Paris | Healthcare | Biotechnology & Medical Research | €5.43M | -0.8x | -0.03 | €0.70 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Medesis Pharma | Paris | Healthcare | Biotechnology & Medical Research | €4.29M | -1.1x | 0.04 | €0.86 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |